Researchers are now working to design stable micro-bubbles which, combined with ultrasound, can deliver cancer drugs straight to the target tumour.
The project recently started up in Trondheim is called ‘BubbleCAN’ and is based on SINTEF proprietary technology. Researchers are making stable micro-bubbles containing chemotherapeutic drugs.
The bubbles can be used in combination with ultrasound and are highly suitable for inoperable cancers and brain tumours that are difficult to treat using current methods.
Highly targeted therapy – fewer side-effects
Yrr Mørch at SINTEF tells Gemini that in traditional chemotherapy approaches, as little as between 0.001 and 0.01% of the drug injected into the body will reach the target tumour.
The new project will develop bubbles specially designed for ultrasound-based cancer treatments
Image Credit: SINTEF